Kymera Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-13.03-12.56-14.51-18.07
Price/Sales ratio
30.9028.3415.258.29
Earnings per Share (EPS)
$-3.26$-3.38$-2.93$-2.35

Historical Multiples (2018 – 2023)

2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-68.99-35.86-24.47-31.09-8.86-10.11-11.72-24.47
Price/Sales ratio
N/A504.7831.6041.8328.7418.9038.7631.60
Price/Book Value ratio
-43.00-19.903.786.622.743.763.706.62
Price/Cash Flow ratio
-82.9182.7112.20-23.62-8.79-14.45-11.85-23.62
Price/Free Cash Flow ratio
-77.0685.2513.61-23.33-8.63-10.82-11.64-23.33
Price/Earnings Growth ratio
N/A-0.38-0.141.60-0.230.950.27-0.14
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A71.88%-82.47%96.70%93.64%-140.58%N/A-82.47%
Operating Profit Margin
N/A-1438.47%-136.05%-138.03%-344.37%-210.61%-344.37%-138.03%
Pretax Profit Margin
N/A-1405.79%-133.96%-137.60%-330.60%-186.99%-330.60%-137.60%
Net Profit Margin
N/A-1407.36%-129.12%-134.54%-324.24%-186.99%-330.60%-134.54%
Effective Tax Rate
-0.20%-0.11%3.61%2.21%1.92%N/AN/A2.21%
Return on Assets
-48.53%-35.38%-9.02%-16.17%-25.17%-25.52%-25.66%-16.17%
Return On Equity
62.33%55.49%-15.47%-21.32%-30.97%-37.20%-33.84%-21.32%
Return on Capital Employed
-54.24%-51.38%-12.29%-19.91%-29.86%-33.77%-30.32%-19.91%
Liquidity Ratios
Current Ratio
N/AN/A2.73N/AN/AN/A5.872.73
Quick Ratio
8.912.684.215.709.034.725.744.21
Cash ratio
8.802.190.280.471.081.280.950.28
Days of Sales Outstanding
N/AN/A15.360.6719.7787.1319.7715.36
Days of Inventory outstanding
N/AN/A-960.24-1.36K-1.50KN/AN/A-960.24
Operating Cycle
N/AN/A-944.88-1.36K-1.48K87.13N/A-944.88
Days of Payables Outstanding
3.66K1.44K25.67609.85531.4913.65N/A609.85
Cash Conversion Cycle
N/A-1.44K-970.55-1.97K-2.01K73.47N/A-970.55
Debt Ratios
Debt Ratio
N/AN/A0.030.020.020.140.180.03
Debt Equity Ratio
N/AN/A0.060.030.030.210.230.06
Long-term Debt to Capitalization
N/AN/A0.040.030.020.160.020.03
Total Debt to Capitalization
N/AN/A0.050.030.030.170.030.03
Interest Coverage Ratio
N/AN/A-402.64N/AN/AN/A-911.04N/A
Cash Flow to Debt Ratio
N/AN/A4.89-7.17-8.83-1.21-8.83-7.17
Company Equity Multiplier
-1.28-1.561.711.311.231.451.231.31
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A6.102.58-1.77-3.26-1.30-3.26-1.77
Free Cash Flow / Operating Cash Flow Ratio
1.070.970.891.011.011.331.010.89
Cash Flow Coverage Ratio
N/AN/A4.89-7.17-8.83-1.21-8.83-7.17
Short Term Coverage Ratio
N/AN/A27.02-35.82-38.82-16.20-38.82-35.82
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A